{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:35Z","timestamp":1786980575967,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key natural science project of Bengbu Medical University","award":["No.2023byzd067"],"award-info":[{"award-number":["No.2023byzd067"]}]},{"name":"Key Project in Natural Science of Anhui Provincial Department of Education","award":["No. 2024AH051257"],"award-info":[{"award-number":["No. 2024AH051257"]}]},{"name":"Clinical Research Special Fund of Wu Jieping Medical Foundation","award":["No. 320.6750.2024-21-125"],"award-info":[{"award-number":["No. 320.6750.2024-21-125"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02126-2","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:47:25Z","timestamp":1774676845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CXCL12-mediated T cell infiltration drives breast cancer metastasis"],"prefix":"10.1007","volume":"26","author":[{"given":"Xianfu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongsheng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"issue":"7","key":"2126_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41419-023-05944-4","volume":"14","author":"C Xu","year":"2023","unstructured":"Xu C, Yang K, Xuan Z, Li J, Liu Y, Zhao Y, Zheng Z, Bai Y, Shi Z, Shao C, et al. BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1. Cell Death Dis. 2023;14(7):445.","journal-title":"Cell Death Dis"},{"key":"2126_CR2","doi-asserted-by":"crossref","unstructured":"Joanne K, Andrew H, Valerie M, Hyuna S, Nehmat H, Eileen M, Miriam M, Gail G, Isabelle S. Miranda M F-B: Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025; 31(4):1154\u201362.","DOI":"10.1038\/s41591-025-03502-3"},{"key":"2126_CR3","doi-asserted-by":"crossref","unstructured":"Wang H, Zhou Y, Zhang Y, Fang S, Zhang M, Li H, Xu F, Liu L, Liu J, Zhao Q et al. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target. J Immunother Cancer. 2022; 10(4):e004302.","DOI":"10.1136\/jitc-2021-004302"},{"key":"2126_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semcancer.2022.10.006","volume":"87","author":"M Castaneda","year":"2022","unstructured":"Castaneda M, den Hollander P, Kuburich N, Rosen J, Mani S. Mechanisms of cancer metastasis. Sem Cancer Biol. 2022;87:17\u201331.","journal-title":"Sem Cancer Biol"},{"issue":"1","key":"2126_CR5","first-page":"16","volume":"11","author":"M Risk","year":"2009","unstructured":"Risk M, Corman J. The role of immunotherapy in prostate cancer: an overview of current approaches in development. Rev Urol. 2009;11(1):16\u201327.","journal-title":"Rev Urol"},{"issue":"3","key":"2126_CR6","doi-asserted-by":"publisher","first-page":"188720","DOI":"10.1016\/j.bbcan.2022.188720","volume":"1877","author":"X Li","year":"2022","unstructured":"Li X, Shen Y, Zhang L, Guo X, Wu J. Understanding initiation and progression of hepatocellular carcinoma through single cell sequencing. Biochim et Biophys acta Reviews cancer. 2022;1877(3):188720.","journal-title":"Biochim et Biophys acta Reviews cancer"},{"issue":"1","key":"2126_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2967\/jnumed.122.264097","volume":"64","author":"M Sako","year":"2023","unstructured":"Sako M, Larimer B. Imaging of Activated T Cells. J nuclear medicine: official publication Soc Nuclear Med. 2023;64(1):30\u20133.","journal-title":"J nuclear medicine: official publication Soc Nuclear Med"},{"key":"2126_CR8","doi-asserted-by":"crossref","unstructured":"Shadbad MA, Safaei S, Brunetti O, Derakhshani A, Lotfinejad P, Mokhtarzadeh A, Hemmat N, Racanelli V, Solimando AG, Argentiero A et al. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Genes. 2021; 12(8):1206.","DOI":"10.3390\/genes12081206"},{"issue":"1","key":"2126_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40618-021-01621-5","volume":"45","author":"M Sottili","year":"2022","unstructured":"Sottili M, Filardi T, Cantini G, Cosmi L, Morano S, Luconi M, Lenzi A, Crescioli C. Human cell-based anti-inflammatory effects of rosiglitazone. J Endocrinol Investig. 2022;45(1):105\u201314.","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"2126_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/path.2819","volume":"223","author":"D Berghuis","year":"2011","unstructured":"Berghuis D, Santos S, Baelde H, Taminiau A, Egeler R, Schilham M, Hogendoorn P, Lankester A. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression. J Pathol. 2011;223(3):347\u201357.","journal-title":"J Pathol"},{"issue":"4","key":"2126_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cytogfr.2010.03.004","volume":"21","author":"H Nomiyama","year":"2010","unstructured":"Nomiyama H, Osada N, Yoshie O. The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev. 2010;21(4):253\u201362.","journal-title":"Cytokine Growth Factor Rev"},{"key":"2126_CR12","doi-asserted-by":"publisher","first-page":"676135","DOI":"10.3389\/fonc.2021.676135","volume":"11","author":"A Clark","year":"2021","unstructured":"Clark A, Heusey H, Griffith L, Lauffenburger D, Wells A. IP-10 (CXCL10) Can Trigger Emergence of Dormant Breast Cancer Cells in a Metastatic Liver Microenvironment. Front Oncol. 2021;11:676135.","journal-title":"Front Oncol"},{"issue":"2","key":"2126_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cncr.20747","volume":"103","author":"T Suyama","year":"2005","unstructured":"Suyama T, Furuya M, Nishiyama M, Kasuya Y, Kimura S, Ichikawa T, Ueda T, Nikaido T, Ito H, Ishikura H. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma. Cancer. 2005;103(2):258\u201367.","journal-title":"Cancer"},{"issue":"11","key":"2126_CR14","first-page":"1489","volume":"91","author":"N Giuliani","year":"2006","unstructured":"Giuliani N, Bonomini S, Romagnani P, Lazzaretti M, Morandi F, Colla S, Tagliaferri S, Lasagni L, Annunziato F, Crugnola M, et al. CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival. Haematologica. 2006;91(11):1489\u201397.","journal-title":"Haematologica"},{"issue":"3","key":"2126_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/labinvest.3780248","volume":"81","author":"M Garc\u00eda-L\u00f3pez","year":"2001","unstructured":"Garc\u00eda-L\u00f3pez M, S\u00e1nchez-Madrid F, Rodr\u00edguez-Frade J, Mellado M, Acevedo A, Garc\u00eda M, Albar J, Mart\u00ednez C, Marazuela M. CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest. 2001;81(3):409\u201318.","journal-title":"Lab Invest"},{"issue":"4","key":"2126_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2011.300","volume":"2","author":"M Liu","year":"2011","unstructured":"Liu M, Guo S, Stiles J. The emerging role of CXCL10 in cancer (Review). Oncol Lett. 2011;2(4):583\u20139.","journal-title":"Oncol Lett"},{"issue":"2","key":"2126_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/icb.2010.158","volume":"89","author":"J Groom","year":"2011","unstructured":"Groom J, Luster A. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011;89(2):207\u201315.","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"2126_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli K, Pillarisetty V, Kim T. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 2022;29(1):10\u201321.","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"2126_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1158\/1078-0432.CCR-11-3314","volume":"19","author":"A Mulligan","year":"2013","unstructured":"Mulligan A, Raitman I, Feeley L, Pinnaduwage D, Nguyen L, O\u2019Malley F, Ohashi P, Andrulis I. Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry. Clin cancer research: official J Am Association Cancer Res. 2013;19(2):336\u201346.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"22","key":"2126_CR20","doi-asserted-by":"publisher","first-page":"11064","DOI":"10.18632\/oncotarget.2519","volume":"5","author":"S Lunardi","year":"2014","unstructured":"Lunardi S, Jamieson N, Lim S, Griffiths K, Carvalho-Gaspar M, Al-Assar O, Yameen S, Carter R, McKay C, Spoletini G, et al. IP-10\/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival. Oncotarget. 2014;5(22):11064\u201380.","journal-title":"Oncotarget"},{"issue":"11","key":"2126_CR21","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"B Teicher","year":"2010","unstructured":"Teicher B, Fricker S. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin cancer research: official J Am Association Cancer Res. 2010;16(11):2927\u201331.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"1","key":"2126_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/pancan.2019.0018","volume":"6","author":"M O\u2019Hara","year":"2020","unstructured":"O\u2019Hara M, Messersmith W, Kindler H, Zhang W, Pitou C, Szpurka A, Wang D, Peng S, Vangerow B, Khan A, et al. Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors. J Pancreat cancer. 2020;6(1):21\u201331.","journal-title":"J Pancreat cancer"},{"key":"2126_CR23","doi-asserted-by":"crossref","unstructured":"Wang Z, Moresco P, Yan R, Li J, Gao Y, Biasci D, Yao M, Pearson J, Hechtman J, Janowitz T et al. Carcinomas assemble a filamentous CXCL12-keratin-19 coating that suppresses T cell-mediated immune attack. Proc Natl Acad Sci USA. 2022; 119(4):e2119463119.","DOI":"10.1073\/pnas.2119463119"},{"issue":"17","key":"2126_CR24","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","volume":"26","author":"W Zhou","year":"2019","unstructured":"Zhou W, Guo S, Liu M, Burow M, Wang G. Targeting CXCL12\/CXCR4 Axis in Tumor Immunotherapy. Curr Med Chem. 2019;26(17):3026\u201341.","journal-title":"Curr Med Chem"},{"issue":"1","key":"2126_CR25","doi-asserted-by":"publisher","first-page":"2118210","DOI":"10.1080\/2162402X.2022.2118210","volume":"11","author":"X Li","year":"2022","unstructured":"Li X, Lu M, Yuan M, Ye J, Zhang W, Xu L, Wu X, Hui B, Yang Y, Wei B, et al. CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy. Oncoimmunology. 2022;11(1):2118210.","journal-title":"Oncoimmunology"},{"key":"2126_CR26","doi-asserted-by":"crossref","unstructured":"Ryuma T, Wu Z, Madiha N, Alberto P, Martin DB, Shivani S, Michelle M, Hideo B, Heinz-Josef L. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2017;63:40-47.","DOI":"10.1016\/j.ctrv.2017.11.007"},{"key":"2126_CR27","doi-asserted-by":"crossref","unstructured":"Yuan N, Chao L, Qi L, Xuan Z. CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling. BMC Cancer. 2023;23(1):150.","DOI":"10.1186\/s12885-023-10615-w"},{"key":"2126_CR28","doi-asserted-by":"crossref","unstructured":"Wei Y, Lin Q, Meiling Y, Anran X, Manqi M, Qinzi Y, Xiaochen M, Wenjuan L, Xuenong L, Yanxia L. CXCL10 mediates CD8(+) T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer. Cancer Lett. 2023;567:216263.","DOI":"10.1016\/j.canlet.2023.216263"},{"key":"2126_CR29","doi-asserted-by":"crossref","unstructured":"Huilian B, Bin S, Feng G, Cheng L, Xuehai G, Changbin K, Fei C, Antentor Othrell H Jr, Hongbing X, Hui Y et al. Spinal IFN-\u03b3-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res Treat. 2013;143(2):255-63.","DOI":"10.1007\/s10549-013-2807-4"},{"key":"2126_CR30","doi-asserted-by":"crossref","unstructured":"Zhijun H, Peizhen W, Kang W, Xujin W, Wen X, Shihao R, Xin C, Jingjing H, Huiqin Z. The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis. BMC Cancer. 2024;24(1):141.","DOI":"10.1186\/s12885-024-11878-7"},{"key":"2126_CR31","unstructured":"CNCB-NGDC Members and Partners. Database Resources of the National Genomics Data Center. China National Center for Bioinformation in 2024. Nucleic Acids Res. 2024;52(D1):D18-D32."},{"key":"2126_CR32","doi-asserted-by":"crossref","unstructured":"Ineta P, Art\u016brs \u0100, L\u012bga S, K\u0101rlis P, El\u012bna Z, Kaspars J, Edgars E, Alicia L, Aija L, Una R. Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages. Cell Commun Signal. 2018;16(1):17.","DOI":"10.1186\/s12964-018-0229-y"},{"key":"2126_CR33","doi-asserted-by":"crossref","unstructured":"Jonathan HC, Linda TN, Maxwell S, Vjola J, Liad E, Peter R, Katherine HX, Roopa M, Milan P, Izabella Z et al. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat Immunol. 2024;25(4):644\u201358.","DOI":"10.1038\/s41590-024-01792-2"},{"issue":"8","key":"2126_CR34","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1158\/0008-5472.CAN-21-2778","volume":"82","author":"R Wei","year":"2022","unstructured":"Wei R, Zhou Y, Li C, Rychahou P, Zhang S, Titlow W, Bauman G, Wu Y, Liu J, Wang C, et al. Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer. Cancer Res. 2022;82(8):1575\u201388.","journal-title":"Cancer Res"},{"key":"2126_CR35","doi-asserted-by":"publisher","first-page":"116335","DOI":"10.1016\/j.envres.2023.116335","volume":"232","author":"N Gupta","year":"2023","unstructured":"Gupta N, Mohan C, Shanmugam M, Jung Y, Chinnathambi A, Alharbi S, Ashrafizadeh M, Mahale M, Bender A, Kumar A, et al. CXCR4 expression is elevated in TNBC patient derived samples and Z-guggulsterone abrogates tumor progression by targeting CXCL12\/CXCR4 signaling axis in preclinical breast cancer model. Environ Res. 2023;232:116335.","journal-title":"Environ Res"},{"issue":"32","key":"2126_CR36","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1038\/s41388-018-0263-7","volume":"37","author":"D Ahirwar","year":"2018","unstructured":"Ahirwar D, Nasser M, Ouseph M, Elbaz M, Cuiti\u00f1o M, Kladney R, Varikuti S, Kaul K, Satoskar A, Ramaswamy B, et al. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. 2018;37(32):4428\u201342.","journal-title":"Oncogene"},{"issue":"11","key":"2126_CR37","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li J, Lei W, Wang H, Ni Y, Liu Y, Yan H, Tian Y, Wang Z, Yang Z, et al. CXCL12-CXCR4\/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. Int J Biol Sci. 2023;19(11):3341\u201359.","journal-title":"Int J Biol Sci"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02126-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:21:19Z","timestamp":1775114479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02126-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2126"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02126-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This cell line-based study was exempt from ethics approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors contributed significantly to the work and are in agreement with the content of the manuscript. All the authors gave their consent to the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"205"}}